Shortages of Drugs Containing Controlled Substances: Issues, Effects & Mitigation Efforts
Author:   Denise Jones
Publisher:   Nova Science Publishers Inc
ISBN:  

9781634833165


Pages:   108
Publication Date:   01 September 2015
Format:   Hardback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $424.32 Quantity:  
Add to Cart

Share |

Shortages of Drugs Containing Controlled Substances: Issues, Effects & Mitigation Efforts


Add your own review!

Overview

In the last decade, shortages of prescription drugs containing controlled substances, such as narcotics and stimulants, have increased nationwide, preventing providers and patients from accessing essential medications for treatment. Controlled substances are regulated by DEA because of the potential for abuse and addiction. To prevent diversion of controlled substances, DEA sets quotas that limit the amount of certain substances that are available in the United States. This book examines the trends in such shortages; the effect on patients and providers; DEA's administration of the quota process; coordination between DEA and FDA to prevent and mitigate shortages; how DEA manages diversion investigation efforts; and how DEA ensures policies and procedures are followed for investigations and the extent to which it determines the results of its efforts.

Full Product Details

Author:   Denise Jones
Publisher:   Nova Science Publishers Inc
Imprint:   Nova Science Publishers Inc
Weight:   0.338kg
ISBN:  

9781634833165


ISBN 10:   1634833163
Pages:   108
Publication Date:   01 September 2015
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Preface; Drug Shortages: Better Management of the Quota Process for Controlled Substances Needed; Coordination between DEA & FDA Should Be Improved; Prescription Drug Control: DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results; Index.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now